Chiauranib Recruiting Phase 3 Trials for Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04830813Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer